Tumor-like microenvironment in oral lichen planus: evidence of malignant transformation?

References

• Marable DR, Bowers LM, Stout TL, et al. Oral candidiasis following steroid therapy for oral lichen planus. Oral Dis. 2016;22:140–147.
   PubMed Web of Science ®Google Scholar
• Lodi G, Scully C, Carrozzo M, et al. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:40–51.
   PubMed Web of Science ®Google Scholar
• Roopashree MR, Gondhalekar RV, Shashikanth MC, et al. Pathogenesis of oral lichen planus–a review. J Oral Pathol Med. 2010;39:729–734.
   PubMed Web of Science ®Google Scholar
• Lu R, Zhang J, Sun W, et al. Inflammation-related cytokines in oral lichen planus: an overview. J Oral Pathol Med. 2015;44:1–14. Epub 2013/12/18.
   PubMed Web of Science ®Google Scholar
• Krutchkoff DJ, Cutler L, Laskowski S. Oral lichen planus: the evidence regarding potential malignant transformation. J Oral Pathol. 1978;7:1–7. Epub 1978/02/01.
   PubMedGoogle Scholar
• Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review. J Am Dent Assoc. 2014;145:45–56.
   PubMed Web of Science ®Google Scholar
• Casparis S, Borm JM, Tektas S, et al. Oral lichen planus (OLP), oral lichenoid lesions (OLL), oral dysplasia, and oral cancer: retrospective analysis of clinicopathological data from 2002-2011. Oral Maxillofac Surg. 2015;19:149–156.
   PubMedGoogle Scholar
• Budimir V, Richter I, Andabak-Rogulj A, et al. Oral lichen planus - retrospective study of 563 Croatian patients. Medicina Oral Patología Oral Y Cirugia Bucal. 2014;19:e255–e60.
   PubMed Web of Science ®Google Scholar
• McCullough MSANCM. Oral lichen planus: a literature review and update. Arch Dermatol Res. 2016;308:539–551.
   PubMed Web of Science ®Google Scholar
• Mignogna MD, Lo Muzio L, Lo Russo L, et al. Metastases in small thickness oral squamous-cell carcinoma arising in oral lichen planus. Med Oncol. 2001;18:159–163.
   PubMed Web of Science ®Google Scholar
• Wamakulasuriyal S, Johnson NW. van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575–578.
   PubMed Web of Science ®Google Scholar
• Van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of managemnt. Oral Oncol. 2009;45:317–323.
   PubMed Web of Science ®Google Scholar
• Georgakopoulou EA, Achtari MD, Achtaris M, et al. Oral lichen planus as a preneoplastic inflammatory model. J Biomed Biotechnol. 2012;2012:759626–759634.
   PubMedGoogle Scholar
• Otero-Rey EM, Suarez-Alen F, Penamaria-Mallon M, et al. Malignant transformation of oral lichen planus by a chronic inflammatory process. Use of topical corticosteroids to prevent this progression? Acta Odontol Scand. 2014;72:570–577. Epub 2014/05/23.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Moles MA, Scully C, Gil-Montoya JA. Oral lichen planus: controversies surrounding malignant transformation. Oral Dis. 2008;14:229–243.
   PubMed Web of Science ®Google Scholar
• Mohammad S, Alrashdan CA, Cirillo N, et al. Smoking habits and clinical patterns can alter the inflammatory infiltrate in oral lichenoid lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:49–57.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674.
   PubMed Web of Science ®Google Scholar
• Chae YC, Vaira V, Caino MC, et al. Mitochondrial akt regulation of hypoxic tumor reprogramming. Cancer Cell. 2016;30:257–272.
   PubMed Web of Science ®Google Scholar
• Lasry A, Zinger A, Ben-Neriah Y. Inflammatory networks underlying colorectal cancer. Nat Immunol. 2016;17:230–240. Epub 2016/02/18.
   PubMed Web of Science ®Google Scholar
• Geis AL, Fan H, Wu X, et al. Regulatory T-cell response to enterotoxigenic bacteroides fragilis colonization triggers il17-dependent colon carcinogenesis. Cancer Discov. 2015;5:1098–1109. Epub 2015/07/24.
   PubMed Web of Science ®Google Scholar
• Lu K, Yang J, Li DC, et al. Expression and clinical significance of glucose transporter-1 in pancreatic cancer. Oncol Lett. 2016;12:243–249.
   PubMed Web of Science ®Google Scholar
• Patel A, Sant S. Hypoxic tumor microenvironment: opportunities to develop targeted therapies. Biotechnology Advances. 2016;34:803–812.
   PubMed Web of Science ®Google Scholar
• Biddlestone J, Bandarra D, Rocha S. The role of hypoxia in inflammatory disease (review). Int J Mol Med. 2015;35:859–869.
   PubMed Web of Science ®Google Scholar
• Taylor CT, Doherty G, Fallon PG, et al. Hypoxia-dependent regulation of inflammatory pathways in immune cells. J Clin Invest. 2016;126:3716–3724.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang D, Wang X, et al. Hypoxia-inducible miR-182 enhances HIF1alpha signaling via targeting PHD2 and FIH1 in prostate cancer. Sci Rep. 2015;5:12495–12507.
   PubMed Web of Science ®Google Scholar
• Hisamatsu T. Inflammatory bowel disease and colorectal cancer. Nihon Rinsho. 2014;72:56–62. Epub 2014/03/07.
   PubMedGoogle Scholar
• Al-Mohaya MA, Al-Otaibi L, Al-Harthi F, et al. Association of genetic polymorphisms in interferon-gamma, interleukin-6 and transforming growth factor-beta1 gene with oral lichen planus susceptibility. BMC Oral Health. 2016;16:76–84.
   PubMed Web of Science ®Google Scholar
• Whitington T, Gao P, Song W, et al. Gene regulatory mechanisms underpinning prostate cancer susceptibility. Nat Genet. 2016;48:387–397.
   PubMed Web of Science ®Google Scholar
• Yang PY, Miao NF, Lin CW, et al. Impact of maspin polymorphism rs2289520 g/c and its interaction with gene to gene, alcohol consumption increase susceptibility to oral cancer occurrence. PLoS One. 2016;11:e0160841–e52.
   Web of Science ®Google Scholar
• Munoz-Guerra MF, Fernandez-Contreras ME, Moreno AL, et al. Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer. Ann Surg Oncol. 2009;16:2351–2358.
   PubMed Web of Science ®Google Scholar
• Ding M, Xu JY, Fan Y. Altered expression of mRNA for HIF-1alpha and its target genes RTP801 and VEGF in patients with oral lichen planus. Oral Dis. 2010;16:299–304.
   PubMed Web of Science ®Google Scholar
• De Carvalho Fraga CA, Alves LR, Marques-Silva L, et al. High HIF-1alpha expression genotypes in oral lichen planus. Clin Oral Investig. 2013;17:2011–2015.
   PubMed Web of Science ®Google Scholar
• Yan Q, Chen P, Wang ST, et al. Association between HIF-1α C1772T/G1790A polymorphisms and cancer susceptibility: an updated systematic review and meta-analysis based on 40 case-control studies. BMC Cancer. 2014;14:950–965.
   PubMed Web of Science ®Google Scholar
• Yang X, Zhu HC, Zhang C, et al. HIF-1alpha 1772 C/T and 1790 G/A polymorphisms are significantly associated with higher cancer risk: an updated meta-analysis from 34 case-control studies. PLoS One. 2013;8:e80396–e407.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Lin L, Wang Y, et al. The association between hypoxia-inducible factor-1 alpha gene G1790A polymorphism and cancer risk: a meta-analysis of 28 case-control studies. Cancer Cell Int. 2014;14:37–47.
   PubMed Web of Science ®Google Scholar
• Ranasinghe WK, Baldwin GS, Bolton D, et al. HIF1alpha expression under normoxia in prostate cancer–which pathways to target? J Urol. 2015;193:763–770.
   PubMed Web of Science ®Google Scholar
• Hua S, Dias TH. Hypoxia-Inducible Factor (HIF) as a target for novel therapies in rheumatoid arthritis. Front Pharmacol. 2016;7:184–192.
   PubMed Web of Science ®Google Scholar
• Taylor CT. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J Physiol. 2008;586:4055–4059.
   PubMed Web of Science ®Google Scholar
• Zhou G, Xia K, Du GF, et al. Activation of nuclear factor-kappa B correlates with tumor necrosis factor-alpha in oral lichen planus: a clinicopathologic study in atrophic-erosive and reticular form. J Oral Pathol Med. 2009;38:559–564.
   PubMed Web of Science ®Google Scholar
• Zhang D, Wang J, Li Z, et al. The activation of nf-kappab in infiltrated mononuclear cells negatively correlates with Treg cell frequency in oral lichen planus. Inflammation. 2015;38:1683–1689. Epub 2015/03/13.
   PubMed Web of Science ®Google Scholar
• Sun HY, Zhou GM, Wang Q, et al. In vitro culture system for keratinocytes obtained from oral lichen planus lesions. Clin Oral Investig. 2014;18:1195–1203. Epub 2013/08/21.
   PubMed Web of Science ®Google Scholar
• Lin XC, Sun HY, Zhen YX, et al. Low expression of glucocorticoid receptor a in oral lichen planus correlates with activation of nuclear factor kappaB: a preliminary study. J Oral Pathol Med. 2014;43:600–605. Epub 2014/10/17.
   PubMed Web of Science ®Google Scholar
• Vlantis K, Wullaert A, Sasaki Y, et al. Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice. J Clin Invest. 2011;121:2781–2793. Epub 2011/06/28.
   PubMed Web of Science ®Google Scholar
• Zhang YN, Liu J, Wang SB, et al. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1a-dependent and -independent manners. Oncotarget. 2016;7:23740–23756.
   PubMed Web of Science ®Google Scholar
• Scardina GA, Ruggieri A, Maresi E, et al. Angiogenesis in oral lichen planus: an in vivo and immunohistological evaluation. Arch Immunol Ther Exp (Warsz). 2011;59:457–462.
   PubMed Web of Science ®Google Scholar
• Martano M, Restucci B, Ceccarelli DM, et al. Immunohistochemical expression of vascular endothelial growth factor in canine oral squamous cell carcinomas. Oncol Lett. 2016;11:399–404.
   PubMed Web of Science ®Google Scholar
• Hung PS, Tu HF, Kao SY, et al. miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes. Carcinogenesis. 2014;35:1162–1171.
   PubMed Web of Science ®Google Scholar
• Tao X, Huang Y, Li R, et al. Assessment of local angiogenesis and vascular endothelial growth factor in the patients with atrophic-erosive and reticular oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:661–669.
   PubMed Web of Science ®Google Scholar
• Gavalas NG, Tsiatas M, Tsitsilonis O, et al. VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2. Br J Cancer. 2012;107:1869–1875.
   PubMed Web of Science ®Google Scholar
• Piechota-Polanczyk A, Fichna J. Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases. Naunyn Schmiedebergs Arch Pharmacol. 2014;387:605–620.
   PubMed Web of Science ®Google Scholar
• Mencalha A, Victorino VJ, Cecchini R, et al. Mapping oxidative changes in breast cancer: understanding the basic to reach the clinics. Anticancer Res. 2014;34:1127–1140. Epub 2014/03/07.
   PubMed Web of Science ®Google Scholar
• Bouzid D, Gargouri B, Mansour RB, et al. Oxidative stress markers in intestinal mucosa of Tunisian inflammatory bowel disease patients. Saudi J Gastroenterol. 2013;19:131–135.
   PubMed Web of Science ®Google Scholar
• Zhu H, Li YR. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Exp Biol Med (Maywood). 2012;237:474–480.
   PubMed Web of Science ®Google Scholar
• Incebiyik A, Camuzcuoglu H, Vural M, et al. Assessment of apoptotic activity dysregulation and oxidative stress in the development of epithelial ovarian cancer: a case-controlled descriptive analysis. Gynecol Obstet Invest. 2016;81:71–77. Epub 2015/06/06.
   PubMed Web of Science ®Google Scholar
• Agha-Hosseini F, Mirzaii-Dizgah I, Farmanbar N, et al. Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma. J Oral Pathol Med. 2012;41:736–740.
   PubMed Web of Science ®Google Scholar
• Totan A, Miricescu D, Parlatescu I, et al. Possible salivary and serum biomarkers for oral lichen planus. Biotech Histochem. 2015;90:552–558.
   PubMed Web of Science ®Google Scholar
• Dincer Y, Erzin Y, Himmetoglu S, et al. Oxidative DNA damage and antioxidant activity in patients with inflammatory bowel disease. Dig Dis Sci. 2007;52:1636–1641.
   PubMed Web of Science ®Google Scholar
• Ohnishi S, Ma N, Thanan R, et al. DNA damage in inflammation-related carcinogenesis and cancer stem cells. Oxid Med Cell Longev. 2013;2013:387014–387022.
   PubMed Web of Science ®Google Scholar
• Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2ʹ -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009;27:120–139. Epub 2009/05/05.
   PubMed Web of Science ®Google Scholar
• Xu X, Wang Y, Guo W, et al. The significance of the alteration of 8-OHdG in serous ovarian carcinoma. J Ovarian Res. 2013;6:74–82. Epub 2013/10/30.
   PubMed Web of Science ®Google Scholar
• Kaur J, Politis C, Jacobs R. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action. Clin Oral Investig. 2016;20:315–319.
   PubMed Web of Science ®Google Scholar
• Nagini S, Letchoumy PV, Thangavelu A, et al. Of humans and hamsters: a comparative evaluation of carcinogen activation, DNA damage, cell proliferation, apoptosis, invasion, and angiogenesis in oral cancer patients and hamster buccal pouch carcinomas. Oral Oncol. 2009;45:e31–7.
   PubMed Web of Science ®Google Scholar
• Chaiyarit P, Ma N, Hiraku Y, et al. Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Sci. 2005;96:553–559.
   PubMed Web of Science ®Google Scholar
• Perl A. mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging. Ann N Y Acad Sci. 2015;1346:2239–2250. Epub 2015/04/25.
   Web of Science ®Google Scholar
• Prodromidis G, Nikitakis NG, Sklavounou A. Immunohistochemical analysis of the activation status of the akt/mtor/ps6 signaling pathway in oral lichen planus. Int J Dent. 2013;2013:743456.
   PubMedGoogle Scholar
• Farah CS, Woo SB, Zain RB, et al. Oral cancer and oral potentially malignant disorders. Int J Dent. 2014;2014:853479.
   PubMedGoogle Scholar
• Dodd KM, Yang J, Shen MH, et al. mTORC1 drives HIF-1alpha and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene. 2015;34:2239–2250.
   PubMed Web of Science ®Google Scholar
• Nazio F, Strappazzon F, Antonioli M, et al. mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6. Nat Cell Biol. 2013;15:406–416.
   PubMed Web of Science ®Google Scholar
• Naruse T, Kawasaki G, Yanamoto S, et al. Immunohistochemical study of vegf expression in oral squamous cell carcinomas: correlation with the mTOR–HIF-1α pathway. Anticancer Res. 2011;31:4429–4437.
   PubMed Web of Science ®Google Scholar
• Krishnan R, Thayalan DK, Padmanaban R, et al. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease. Asian Pac J Cancer Prev. 2014;15:7141–7148.
   PubMedGoogle Scholar
• Malarkodi T, Sathasivasubramanian S. Quantitative analysis of salivary TNF-alpha in oral lichen planus patients. Int J Dent. 2015;2015:283465–283469.
   PubMedGoogle Scholar
• Skrinjar I, Brailo V, Vidovic-Juras D, et al. Evaluation of pretreatment serum interleukin-6 and tumour necrosis factor alpha as a potential biomarker for recurrence in patients with oral squamous cell carcinoma. Medicina Oral Patología Oral Y Cirugia Bucal. 2015;20:e402–e7.
   PubMed Web of Science ®Google Scholar
• Hu S, Chen WC, Hwang GS, et al. Changes in plasma steroids and cytokines levels in betel chewing patients in Taiwan. Steroids. 2016;111:134–138.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lin M, Zhang S, et al. NF-kappaB-dependent cytokines in saliva and serum from patients with oral lichen planus: a study in an ethnic Chinese population. Cytokine. 2008;41:144–149.
   PubMed Web of Science ®Google Scholar
• Rhodus NL, Cheng B, Ondrey F. Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus. Mediators Inflamm. 2007;2007:19854–19858.
   PubMed Web of Science ®Google Scholar
• Jackson-Bernitsas DG, Ichikawa H, Takada Y, et al. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene. 2007;26:1385–1397.
   PubMed Web of Science ®Google Scholar
• Yang JP, Hyun MH, Yoon JM, et al. Association between TNF-alpha-308 G/A gene polymorphism and gastric cancer risk: a systematic review and meta-analysis. Cytokine. 2014;70:104–114.
   PubMed Web of Science ®Google Scholar
• Al-Mohaya MA, Al-Harthi F, Arfin M, et al. TNF-alpha, TNF-beta and IL-10 gene polymorphism and association with oral lichen planus risk in Saudi patients. J Appl Oral Sci. 2015;23:295–301.
   PubMed Web of Science ®Google Scholar
• Xavier GM, De Sa AR, Guimaraes AL, et al. Investigation of functional gene polymorphisms interleukin-1beta, interleukin-6, interleukin-10 and tumor necrosis factor in individuals with oral lichen planus. J Oral Pathol Med. 2007;36:476–481.
   PubMed Web of Science ®Google Scholar
• Kimkong I, Hirankarn N, Nakkuntod J, et al. Tumour necrosis factor-alpha gene polymorphisms and susceptibility to oral lichen planus. Oral Dis. 2011;17:206–209.
   PubMed Web of Science ®Google Scholar
• Jin X, Wang J, Zhu L, et al. Association between −308 G/A polymorphism in TNF-alpha gene and lichen planus: a meta-analysis. J Dermatol Sci. 2012;68:127–134.
   PubMed Web of Science ®Google Scholar
• Bai J, Jiang L, Lin M, et al. Association of polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes with oral lichen planus: a study in a Chinese cohort with Han ethnicity. J Interferon Cytokine Res. 2009;29:381–388.
   PubMed Web of Science ®Google Scholar
• Yang Y, Luo C, Feng R, et al. The TNF-alpha, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol. 2011;137:947–952.
   PubMed Web of Science ®Google Scholar
• Sousa H, Oliveira S, Santos AM, et al. Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer. Tumour Biol. 2014;35:2561–2564.
   PubMed Web of Science ®Google Scholar
• Nibali L, Fedele S, D’Aiuto F, et al. Interleukin-6 in oral diseases: a review. Oral Dis. 2012;18:236–243.
   PubMed Web of Science ®Google Scholar
• Bromberg J, Wang TC. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell. 2009;15:79–80.
   PubMed Web of Science ®Google Scholar
• Bollrath J, Phesse TJ, Von Burstin VA, et al. gp130-Mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell. 2009;15:91–102.
   PubMed Web of Science ®Google Scholar
• Jinno T, Kawano S, Maruse Y, et al. Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma. Oncol Rep. 2015;33:2161–2168.
   PubMed Web of Science ®Google Scholar
• Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009;15:103–113.
   PubMed Web of Science ®Google Scholar
• Goel S, Marwah A, Kaushik S, et al. Role of serum interleukin-6 in deciding therapy for multidrug resistant oral lichen planus. J Clin Exp Dent. 2015;7:e477–e82.
   PubMedGoogle Scholar
• Towle R, Truong D, Hogg K, et al. Global analysis of DNA methylation changes during progression of oral cancer. Oral Oncol. 2013;49:1033–1042.
   PubMed Web of Science ®Google Scholar
• Gasche JA, Hoffmann J, Boland CR, et al. Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer. 2011;129:1053–1063.
   PubMed Web of Science ®Google Scholar
• Borsig L, Wolf MJ, Roblek M, et al. Inflammatory chemokines and metastasis–tracing the accessory. Oncogene. 2014;33:3217–3224. Epub 2013/07/16.
   PubMed Web of Science ®Google Scholar
• Hu JY, Zhang J, Cui JL, et al. Increasing CCL5/CCR5 on CD4+ T cells in peripheral blood of oral lichen planus. Cytokine. 2013;62:141–145.
   PubMed Web of Science ®Google Scholar
• Thomas T, Murooka RR, Platanias LC, et al. CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1. Blood. 2008;111:4892–4901.
   PubMed Web of Science ®Google Scholar
• Swamydas M, Ricci K, Rego SL, et al. Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases. Cell Adh Migr. 2013;7:315–324.
   PubMed Web of Science ®Google Scholar
• Murooka TT, Rahbar R, Fish EN. CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation. Biochem Biophys Res Commun. 2009;387:381–386.
   PubMed Web of Science ®Google Scholar
• Kim MJ, Kim KM, Kim J, et al. BMP-2 promotes oral squamous carcinoma cell invasion by inducing CCL5 release. PLoS One. 2014;9:e108170–e7.
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Nakashiro K-I, Klosek SK, et al. Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma. Oncology Reports. 2009;21:707–712.
   PubMed Web of Science ®Google Scholar
• Guan G, Zhang Y, Lu Y, et al. The HIF-1alpha/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells. Cancer Lett. 2015;357:254–264.
   PubMed Web of Science ®Google Scholar
• Ichimura M, Hiratsuka K, Ogura N, et al. Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus. J Oral Pathol Med. 2006;35:167–174.
   PubMed Web of Science ®Google Scholar
• Chen N, Jiang X, Wang J, et al. CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma. Tumor Biol. 2016;37:567–575.
   PubMed Web of Science ®Google Scholar
• Yu T, Wu Y, Huang Y, et al. RNAi targeting CXCR4 inhibits tumor growth through inducing cell cycle arrest and apoptosis. Mol Ther. 2012;20:398–407. Epub 2011/11/24.
   PubMed Web of Science ®Google Scholar
• Zhang C, Li J, Han Y, et al. A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer. Drug Des Devel Ther. 2015;9:3267–3278.
   PubMed Web of Science ®Google Scholar
• Vered M, Furth E, Shalev Y, et al. Inflammatory cells of immunosuppressive phenotypes in oral lichen planus have a proinflammatory pattern of expression and are associated with clinical parameters. Clin Oral Investig. 2013;17:1365–1373.
   PubMed Web of Science ®Google Scholar
• Li X, Zheng Y. Regulatory T cell identity: formation and maintenance. Trends Immunol. 2015;36:344–353.
   PubMed Web of Science ®Google Scholar
• Wang W, Shao S, Jiao Z, et al. The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol Int. 2012;32:887–893.
   PubMed Web of Science ®Google Scholar
• Ito Y, Adachi Y, Makino; T, et al. Expansion of FOXP3-positive CD4+CD25+T cells associated with disease activity in atopic dermatitis. Ann Allergy Asthma Immunol. 2009;103:160–165.
   PubMed Web of Science ®Google Scholar
• Pesenacker AM, Cook L, Levings MK. The role of FOXP3 in autoimmunity. Curr Opin Immunol. 2016;43:16–23.
   PubMed Web of Science ®Google Scholar
• Tao XA, Xia J, Chen XB, et al. FOXP3 T regulatory cells in lesions of oral lichen planus correlated with disease activity. Oral Dis. 2010;16:76–82.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li J, Bai Y, et al. Hydroxychloroquine decreases the upregulated frequencies of Tregs in patients with oral lichen planus. Clin Oral Investig. 2014;18:1903–1911.
   PubMed Web of Science ®Google Scholar
• Rakebrandt N, Littringer K, Joller N. Regulatory T cells: balancing protection versus pathology. Swiss Med Wkly. 2016;146:w14343–w50. Epub 2016/08/09.
   PubMed Web of Science ®Google Scholar
• Pastille E, Bardini K, Fleissner D, et al. Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer. Cancer Res. 2014;74:4258–4269.
   PubMed Web of Science ®Google Scholar
• Probst-Kepper M, Geffers R, Kroger A, et al. GARP: a key receptor controlling FOXP3 in human regulatory T cells. J Cell Mol Med. 2009;13:3343–3357.
   PubMed Web of Science ®Google Scholar
• Kalathil S, Lugade AA, Miller A, et al. Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality. Cancer Res. 2013;73:2435–2444.
   PubMed Web of Science ®Google Scholar
• Anz D, Mueller W, Golic M, et al. CD103 is a hallmark of tumor-infiltrating regulatory T cells. Int J Cancer. 2011;129:2417–2426.
   PubMed Web of Science ®Google Scholar
• Shen Z, Gao X, Ma L, et al. Expression of Foxp3 and interleukin-17 in lichen planus lesions with emphasis on difference in oral and cutaneous variants. Arch Dermatol Res. 2014;306:441–446.
   PubMed Web of Science ®Google Scholar
• Cho YA, Yoon HJ, Lee JI, et al. Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma. Oral Oncol. 2011;47:1148–1153.
   PubMed Web of Science ®Google Scholar
• Xu F, Feng G, Zhao H, et al. Prognostic value of b7 homolog 1 in gastric cancer: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94:e1911–e7.
   PubMed Web of Science ®Google Scholar
• Liu C, Jiang J, Gao L, et al. Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways. Arthritis Res Ther. 2015;17:340–352.
   PubMed Web of Science ®Google Scholar
• Zhou G, Zhang J, Ren XW, et al. Increased B7-H1 expression on peripheral blood T cells in oral lichen planus correlated with disease severity. J Clin Immunol. 2012;32:794–801.
   PubMed Web of Science ®Google Scholar
• Xylinas E, Robinson BD, Kluth LA, et al. Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder. Eur J Surg Oncol. 2014;40:121–127.
   PubMed Web of Science ®Google Scholar
• Song M, Chen D, Lu B, et al. PTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancer. PLoS One. 2013;8:e65821–e31.
   PubMed Web of Science ®Google Scholar
• Iwasaki K, Yabushita H, Ueno T, et al. Role of hypoxia-inducible factor-1alpha, carbonic anhydrase-IX, glucose transporter-1 and vascular endothelial growth factor associated with lymph node metastasis and recurrence in patients with locally advanced cervical cancer. Oncol Lett. 2015;10:1970–1978.
   PubMed Web of Science ®Google Scholar
• Zeng L, Zhou HY, Tang NN, et al. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells. World J Gastroenterol. 2016;22:4868–4880.
   PubMed Web of Science ®Google Scholar
• Bostrom PJ, Thoms J, Sykes J, et al. Hypoxia marker GLUT-1 (glucose transporter 1) is an independent prognostic factor for survival in bladder cancer patients treated with radical cystectomy. Bladder Cancer. 2016;2:101–109.
   PubMed Web of Science ®Google Scholar
• Angadi VC, Angadi PV. GLUT-1 immunoexpression in oral epithelial dysplasia, oral squamous cell carcinoma, and verrucous carcinoma. J Oral Sci. 2015;57:115–122.
   PubMed Web of Science ®Google Scholar
• Marius G, Bredell JE, El-Kochairi I, et al. Current relevance of hypoxia in head and neck cancer. Oncotarget. 2016;7:50781–50804.
   PubMed Web of Science ®Google Scholar
• Al-Sharaky DR. HIF-1 a and GLUT-1 expression in atypical endometrial hyperplasia, type i and ii endometrial carcinoma: a potential role in pathogenesis. J Clin Diagn Res. 2016;10:EC20–EC7.
   PubMed Web of Science ®Google Scholar
• Li S, Yang X, Wang P, et al. The effects of GLUT1 on the survival of head and neck squamous cell carcinoma. Cell Physiol Biochem. 2013;32:624–634.
   PubMed Web of Science ®Google Scholar
• Zhang X, Han S, Han HY, et al. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression. Pathology. 2013;45:478–483. Epub 2013/07/03.
   PubMed Web of Science ®Google Scholar
• Jamali S, Klier M, Ames S, et al. Hypoxia-induced carbonic anhydrase IX facilitates lactate flux in human breast cancer cells by non-catalytic function. Sci Rep. 2015;5:13605–13620.
   PubMed Web of Science ®Google Scholar
• Sedlakova O, Svastova E, Takacova M, et al. Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors. Front Physiol. 2014;4:400–413.
   PubMed Web of Science ®Google Scholar
• Kwon JE, Jung WH, Koo JS. The expression of metabolism-related proteins in phyllodes tumors. Tumour Biol. 2013;34:115–124.
   PubMed Web of Science ®Google Scholar